- Home
- CVAC vs REX Comparison
CVAC vs REX Comparison
Compare CVAC & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- REX
- Stock Information
- Founded
- CVAC 2000
- REX 1980
- Country
- CVAC Germany
- REX United States
- Employees
- CVAC N/A
- REX N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- REX Major Chemicals
- Sector
- CVAC Health Care
- REX Industrials
- Exchange
- CVAC Nasdaq
- REX Nasdaq
- Market Cap
- CVAC 764.4M
- REX 699.5M
- IPO Year
- CVAC 2020
- REX N/A
- Fundamental
- Price
- CVAC $4.47
- REX $42.15
- Analyst Decision
- CVAC Strong Buy
- REX Strong Buy
- Analyst Count
- CVAC 2
- REX 1
- Target Price
- CVAC $14.00
- REX $50.00
- AVG Volume (30 Days)
- CVAC 779.9K
- REX 103.9K
- Earning Date
- CVAC 05-20-2025
- REX 05-28-2025
- Dividend Yield
- CVAC N/A
- REX N/A
- EPS Growth
- CVAC N/A
- REX N/A
- EPS
- CVAC 0.87
- REX 3.24
- Revenue
- CVAC $566,039,775.00
- REX $639,600,000.00
- Revenue This Year
- CVAC N/A
- REX $3.27
- Revenue Next Year
- CVAC $37.79
- REX $17.11
- P/E Ratio
- CVAC $5.16
- REX $13.02
- Revenue Growth
- CVAC 787.60
- REX N/A
- 52 Week Low
- CVAC $2.37
- REX $33.45
- 52 Week High
- CVAC $5.28
- REX $52.20
- Technical
- Relative Strength Index (RSI)
- CVAC 65.61
- REX 55.64
- Support Level
- CVAC $3.35
- REX $38.88
- Resistance Level
- CVAC $4.80
- REX $43.62
- Average True Range (ATR)
- CVAC 0.30
- REX 1.35
- MACD
- CVAC 0.07
- REX -0.16
- Stochastic Oscillator
- CVAC 77.51
- REX 68.99
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.